AI Summary
This article discusses the development of a new method for diagnosing and treating prostate cancer using prostate-specific membrane antigen-targeted near-infrared (NIR) phototheranostics. The goal is to improve the accuracy and effectiveness of prostate cancer detection and treatment. This innovation has the potential to revolutionize prostate cancer management and improve patient outcomes.